Literature DB >> 11508876

Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a consecutive series in younger patients.

E S Lit1, R Y Kim, D J Damico.   

Abstract

PURPOSE: Subfoveal choroidal neovascularization (CNV) remains a common and important cause of visual loss. Previous studies have suggested that submacular surgery may improve or maintain visual acuity, particularly in younger patients. The majority of reported cases included removal of the posterior hyaloid during vitrectomy. The authors present a consecutive series of patients age 55 or younger with subfoveal CNV removal without posterior hyaloid removal.
METHODS: Seventeen patients without age-related macular degeneration (ARMD), with subfoveal CNV from choroiditis, presumed ocular histoplasmosis syndrome, myopia, or idiopathic causes, underwent a small retinotomy technique to extract the membranes after vitrectomy without posterior hyaloid removal.
RESULTS: Median improvement in visual acuity was from 20/320 to 20/50. Eleven patients (65%) experienced an improvement of three or more lines of Snellen acuity (average 7.5), 4 (23%) were within two lines of preoperative acuity, and 2 (12%) had decreased acuity, with an average follow-up of 12 months (range 3-31). Choroidal neovascularization recurred in six patients (35%). Postoperative retinal detachment, epiretinal proliferation, or macular hole did not occur.
CONCLUSIONS: In this series of younger patients with subfoveal CNV not from ARMD, visual acuity was improved in the majority after submacular membrane removal. Omission of removal of the posterior hyaloid did not adversely affect outcome.

Entities:  

Mesh:

Year:  2001        PMID: 11508876     DOI: 10.1097/00006982-200108000-00004

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

1.  Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation.

Authors:  Alfonso Giovannini; Piergiorgio Neri; Lucia Mercanti; Claudia Bruè
Journal:  Br J Ophthalmol       Date:  2007-01-03       Impact factor: 4.638

2.  Subfoveal choroidal neovascularization complicating 25-gauge trans-retinal choroidal tumor biopsy.

Authors:  Martina Angi; S Khurshid Gibran; Bertil E Damato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-11       Impact factor: 3.117

3.  Inflammatory choroidal neovascularization.

Authors:  Piergiorgi Neri; Marta Lettieri; Cinzia Fortuna; Mara Manoni; Alfonso Giovannini
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

4.  Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series.

Authors:  Piergiorgio Neri; Mara Manoni; Cinzia Fortuna; Marta Lettieri; Cesare Mariotti; Alfonso Giovannini
Journal:  Int Ophthalmol       Date:  2009-09-02       Impact factor: 2.031

5.  Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy after bevacizumab.

Authors:  Sophia I Pachydaki; Frederick A Jakobiec; Pooja Bhat; Lucia Sobrin; Norman A Michaud; Surya V Seshan; Donald J D'Amico
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-11-27

6.  Myopia and inflammation.

Authors:  Carl P Herbort; Marina Papadia; Piergiorgio Neri
Journal:  J Ophthalmic Vis Res       Date:  2011-10

7.  Is subretinal surgery feasible for a non-responsive juxtafoveal type 2 choroidal neovascular membrane?

Authors:  Hugo Quiroz-Mercado; Andrés Lisker-Cervantes; Luis Arroyo; Naresh Mandava; Frank S Siringo; Miguel Paciuc-Beja; Roberto Gonzalez-Salinas
Journal:  Am J Ophthalmol Case Rep       Date:  2019-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.